Syndax Pharma (SNDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -285,422 | -318,758 | -209,360 | -149,338 | 24,926 |
| Depreciation Amortization | -10,519 | -13,430 | -14,791 | -3,349 | 687 |
| Accounts receivable | -36,830 | -11,237 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 4,954 | 1,665 | 5,611 | -1,319 | 2,161 |
| Other Working Capital | -79,318 | 12,807 | 31,860 | 1,656 | -9,597 |
| Other Operating Activity | 84,155 | 54,050 | 26,079 | 18,675 | 10,954 |
| Operating Cash Flow | $-322,980 | $-274,903 | $-160,601 | $-133,675 | $29,131 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 290,223 | -219,775 | 117,609 | -186,413 | -40,744 |
| PPE Investments | -187 | N/A | N/A | 225 | -129 |
| Investing Cash Flow | $290,036 | $-219,775 | $117,609 | $-186,188 | $-40,873 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 343,652 | N/A | N/A | 576 |
| Debt Repayment | N/A | N/A | N/A | -20,996 | N/A |
| Common Stock Issued | 13,676 | 9,715 | 264,132 | 193,250 | 117,888 |
| Financing Cash Flow | $13,676 | $353,367 | $264,132 | $172,254 | $118,464 |
| Beginning Cash Position | 154,300 | 295,611 | 74,471 | 222,080 | 115,358 |
| End Cash Position | 135,032 | 154,300 | 295,611 | 74,471 | 222,080 |
| Net Cash Flow | $-19,268 | $-141,311 | $221,140 | $-147,609 | $106,722 |
| Free Cash Flow | |||||
| Operating Cash Flow | -322,980 | -274,903 | -160,601 | -133,675 | 29,131 |
| Capital Expenditure | -187 | N/A | N/A | N/A | -129 |
| Free Cash Flow | -323,167 | -274,903 | -160,601 | -133,675 | 29,002 |